标题
Antibody‐mediated phagocytosis in cancer immunotherapy
作者
关键词
-
出版物
IMMUNOLOGICAL REVIEWS
Volume 319, Issue 1, Pages 128-141
出版商
Wiley
发表日期
2023-08-22
DOI
10.1111/imr.13265
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acalabrutinib and High-Frequency Low-Dose Subcutaneous Rituximab for Initial Therapy of Chronic Lymphocytic Leukemia
- (2023) Danielle S Wallace et al. Blood Advances
- Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions
- (2023) Jeremiah E. Moore et al. LEUKEMIA RESEARCH
- The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact
- (2022) Jonathan J. Pinney et al. HAEMATOLOGICA
- Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis
- (2021) Chengxin Luo et al. Scientific Reports
- Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis
- (2021) Capucine L. Grandjean et al. Science Advances
- Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis
- (2021) Sofie Vandendriessche et al. Frontiers in Cell and Developmental Biology
- High-resolution quantification of discrete phagocytic events by live cell time-lapse high-content microscopy imaging
- (2020) Charles C. Chu et al. JOURNAL OF CELL SCIENCE
- Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia
- (2020) Jennifer A. Woyach et al. Cancer Discovery
- Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial
- (2020) Jeff P Sharman et al. LANCET
- DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
- (2020) Simone C. Oostindie et al. Blood Cancer Journal
- Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance
- (2020) Jonathan J Pinney et al. BLOOD
- The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
- (2020) Gabriela Pavlasova et al. HAEMATOLOGICA
- Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia
- (2020) Kerry A. Rogers et al. JOURNAL OF CLINICAL ONCOLOGY
- Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
- (2020) Othman Al-Sawaf et al. LANCET ONCOLOGY
- CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
- (2019) Simone C. Oostindie et al. HAEMATOLOGICA
- Mechanisms of lymphoma clearance induced by high-dose alkylating agents
- (2019) Chen Lossos et al. Cancer Discovery
- Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab
- (2018) Ahmed T. Kurdi et al. MOLECULAR CANCER THERAPEUTICS
- Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies
- (2018) Karl R. VanDerMeid et al. Cancer Immunology Research
- Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
- (2018) Shicheng Su et al. CELL
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Immunology of Complement Receptors 3 and 4
- (2018) Thomas Vorup-Jensen et al. Frontiers in Immunology
- Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells
- (2017) Sladjana Skopelja-Gardner et al. JOURNAL OF IMMUNOLOGY
- Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
- (2017) John F Seymour et al. LANCET ONCOLOGY
- Affinity of human IgG subclasses to mouse Fc gamma receptors
- (2017) Gillian Dekkers et al. mAbs
- β2 Integrins As Regulators of Dendritic Cell, Monocyte, and Macrophage Function
- (2017) Leonie Schittenhelm et al. Frontiers in Immunology
- Phagocytosis: The Legacy of Metchnikoff
- (2016) Siamon Gordon CELL
- Maxed out macs: physiologic cell clearance as a function of macrophage phagocytic capacity
- (2016) Clive S. Zent et al. FEBS Journal
- Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
- (2016) Capucine L. Grandjean et al. Scientific Reports
- Antibody-Dependent Phagocytosis of Tumor Cells by Macrophages: A Potent Effector Mechanism of Monoclonal Antibody Therapy of Cancer
- (2015) N. Gul et al. CANCER RESEARCH
- Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages
- (2015) A. K. Church et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling
- (2015) Andrew Getahun et al. IMMUNOLOGICAL REVIEWS
- Fcγ receptor pathways during active and passive immunization
- (2015) Stylianos Bournazos et al. IMMUNOLOGICAL REVIEWS
- Mouse and human FcR effector functions
- (2015) Pierre Bruhns et al. IMMUNOLOGICAL REVIEWS
- Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages
- (2015) Yun Shi et al. JOURNAL OF IMMUNOLOGY
- An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions
- (2015) Michelle Kinder et al. mAbs
- Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
- (2015) Marije B Overdijk et al. mAbs
- Phagocytosis of apoptotic cells in homeostasis
- (2015) Sanja Arandjelovic et al. NATURE IMMUNOLOGY
- Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells
- (2014) Clive S. Zent et al. AMERICAN JOURNAL OF HEMATOLOGY
- Fc -receptor-mediated trogocytosis impacts mAb-based therapies: historical precedence and recent developments
- (2014) R. P. Taylor et al. BLOOD
- Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy
- (2014) F. D. Roit et al. HAEMATOLOGICA
- Macrophages eliminate circulating tumor cells after monoclonal antibody therapy
- (2014) Nuray Gül et al. JOURNAL OF CLINICAL INVESTIGATION
- Complement Receptor of the Ig Superfamily Enhances Complement-Mediated Phagocytosis in a Subpopulation of Tissue Resident Macrophages
- (2014) N. N. Gorgani et al. JOURNAL OF IMMUNOLOGY
- Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between Fc RI and Fc RIV
- (2014) M. A. Otten et al. JOURNAL OF IMMUNOLOGY
- Comparative Functional Evolution of Human and Mouse CR1 and CR2
- (2014) A. C. Jacobson et al. JOURNAL OF IMMUNOLOGY
- Induced Resistance to Ofatumumab-Mediated Cell Clearance Mechanisms, Including Complement-Dependent Cytotoxicity, in Chronic Lymphocytic Leukemia
- (2014) N. A. Baig et al. JOURNAL OF IMMUNOLOGY
- Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study
- (2014) S E M Herman et al. LEUKEMIA
- Type I and type II Fc receptors regulate innate and adaptive immunity
- (2014) Andrew Pincetic et al. NATURE IMMUNOLOGY
- The mechanism of anti-CD20–mediated B cell depletion revealed by intravital imaging
- (2013) Fabricio Montalvao et al. JOURNAL OF CLINICAL INVESTIGATION
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- Crosstalk between Human IgG Isotypes and Murine Effector Cells
- (2012) M. B. Overdijk et al. JOURNAL OF IMMUNOLOGY
- Exhaustion of Cytotoxic Effector Systems May Limit Monoclonal Antibody-Based Immunotherapy in Cancer Patients
- (2012) F. J. Beurskens et al. JOURNAL OF IMMUNOLOGY
- The Cell Biology of Phagocytosis
- (2011) Ronald S. Flannagan et al. Annual Review of Pathology-Mechanisms of Disease
- Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
- (2011) P. V. Beum et al. JOURNAL OF IMMUNOLOGY
- Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
- (2010) Mark P. Chao et al. CELL
- Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes
- (2010) W. EMLEN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Receptor mobility, the cytoskeleton, and particle binding during phagocytosis
- (2010) Valentin Jaumouillé et al. CURRENT OPINION IN CELL BIOLOGY
- Experimentally induced liver metastases from colorectal cancer can be prevented by mononuclear phagocyte-mediated monoclonal antibody therapy
- (2010) Gerben J. van der Bij et al. JOURNAL OF HEPATOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- Pancreatitis and atypical Kawasaki disease
- (2010) Dragan Prokic et al. Pediatric Rheumatology
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions
- (2009) Anna Erdei et al. MOLECULAR IMMUNOLOGY
- Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc RI, Fc RIII, and Fc RIV
- (2008) V. Minard-Colin et al. BLOOD
- Specificity and affinity of human Fc receptors and their polymorphic variants for human IgG subclasses
- (2008) P. Bruhns et al. BLOOD
- Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40
- (2008) E Oflazoglu et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search